Alteration of Chemotaxis in the Gut of IBD Patients

37
KRISTEN DOSTIE Alteration of Chemotaxis in the Gut of IBD Patients

description

Alteration of Chemotaxis in the Gut of IBD Patients. Kristen Dostie. Overview. Introduction What do we know about neutrophil chemotaxis in IBD? Paper 1 Paper 2 What is still unknown about neutrophil chemotaxis in IBD ? Specific Aim. The Inflammatory Response. - PowerPoint PPT Presentation

Transcript of Alteration of Chemotaxis in the Gut of IBD Patients

Page 1: Alteration of  Chemotaxis  in the Gut of IBD Patients

KRISTEN DOSTIE

Alteration of Chemotaxis in the Gut of IBD Patients

Page 2: Alteration of  Chemotaxis  in the Gut of IBD Patients

Overview

IntroductionWhat do we know about neutrophil

chemotaxis in IBD?Paper 1Paper 2What is still unknown about neutrophil

chemotaxis in IBD?Specific Aim

Page 3: Alteration of  Chemotaxis  in the Gut of IBD Patients

The Inflammatory Response

http://www.uic.edu/classes/bios/bios100/lecturesf04am/inflammation01a.jpg

Page 4: Alteration of  Chemotaxis  in the Gut of IBD Patients

How are neutrophils recruited from the bloodstream to the affected area?

CXC chemokines are ligands for CXCR receptors on several different cell types Promote neutrophil migration

Chemotaxis! Movement of a cell in response to a chemical stimulus

Page 5: Alteration of  Chemotaxis  in the Gut of IBD Patients

Neutrophil infiltration is largely mediated through binding of CXCR receptors

Nature Reviews Immunology 13, 649–665 (2013)

Page 6: Alteration of  Chemotaxis  in the Gut of IBD Patients

Overview

IntroductionWhat do we know about neutrophil

chemotaxis in IBD?What is still unknown about neutrophil

chemotaxis in IBD?Paper 1Paper 2Specific Aims

Page 7: Alteration of  Chemotaxis  in the Gut of IBD Patients

What is generally known about neutrophil chemotaxis in IBD?

Invasion of neutrophils into the mucosal epithelium and intestinal lumen correlates with disease activity

Neutrophil infiltration disrupts epithelial barrier integrity Allows lumenal proteins and

microorganisms to breach the submucosa

Neutrophils within the mucosa and submucosa produce proinflammatory signals that perpetuate neutrophil recruitment to the affected area

Page 8: Alteration of  Chemotaxis  in the Gut of IBD Patients

What is generally known about neutrophil chemotaxis in IBD?

Neutrophils release a plethora of inflammatory mediators that can exacerbate inflammation

Inflammatory Bowel Disease. Volume 19, Number 7, June 2013

Page 9: Alteration of  Chemotaxis  in the Gut of IBD Patients

Overview

IntroductionWhat do we know about neutrophil

chemotaxis in IBD?Paper 1Paper 2What is still unknown about neutrophil

chemotaxis in IBD?Specific Aims

Page 10: Alteration of  Chemotaxis  in the Gut of IBD Patients

Paper 1

Page 11: Alteration of  Chemotaxis  in the Gut of IBD Patients

Paper 1 Background

Neutrophils produce proteases that cleave collagen into proline-glycine-proline (PGP) Matrix metalloproteinases

(MMPs) Prolyl endopeptidase (PE)

PGP has been shown to be a chemoattractant for neutrophils via CXCR1/2 in several lung diseases

Goal: to investigate the role of PGP in neutrophil recruitment associated with IBD

Page 12: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 1: Is protease expression upregulated in the colon of IBD patients?

Conclusions:

MMP8 is upregulated in both inflamed and non-inflamed IBD intestinal samples

MMP8 present in IBD patients exists dominantly in its active form

Page 13: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 1 (cont’d): Where do these proteases localize within the intestine?

MMP9: neutrophils

PE: neutrophils and epithelial cells

MMP8: weak expression in neutrophils and inflammatory cells

Page 14: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 2: Are products of MMP and PE activity increased in IBD?

N-Ac-PGP (an acetylated form of PGP) expression is increased in IBD patient intestinal samples.

Page 15: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 3: Do IBD neutrophils produce more proteases and their subsequent products compared

to healthy controls?

Proteases

Chemoattractants

Conclusion: IBD neutrophils produce significantly higher levels of MMP8, MMP9, and N-Ac-PGP in conditioned medium

Page 16: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 4: Protease expression in a DSS-induced colitis model

• PE: no significant difference in expression

• MMP9: significant increase in expression

• MMP8: no significant difference in expression

• Conclusion: protease expression in DSS-induced colitis colon samples is comparable to human IBD tissue levels.

Page 17: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 5: Localization of protease expression in DSS-induced colitis colon tissue

• MMP8: leukocytes and epithelial cells

• MMP9: leukocytes

• PE: leukocytes and epithelial cells

• Conclusion: localization of proteases is comparable to patterns in human disease.

Page 18: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 5 (cont’d): Chemoattractant expression in DSS-colitis colon tissue

Conclusion: N-Ac-PGP and PGP are generated in DSS colon samples, but not at significant levels.

Page 19: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 6: PGP neutralization as a therapeutic for IBD

Conclusion: PGP neutralization reduced disease activity index (DAI), shortening of the colon, histopathological scores, and neutrophil infiltration in the colon.

Page 20: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 7: The PGP generation cascade leads to neutrophil chemotaxis

Page 21: Alteration of  Chemotaxis  in the Gut of IBD Patients

Conclusions from Paper 1

Components of the PGP generation pathway (matrix metalloproteinases and PE) are present in intestines of human IBD patients and DSS-induced colitis mice.

N-Ac-PGP-mediated neutrophil recruitment likely plays a role in the perpetuation of intestinal inflammation of IBD

PGP neutralization reduced neutrophil infiltration and disease activity indices in a DSS-induced colitis model

Page 22: Alteration of  Chemotaxis  in the Gut of IBD Patients

Overview

IntroductionWhat do we know about neutrophil

chemotaxis in IBD?Paper 1Paper 2What is still unknown about neutrophil

chemotaxis in IBD?Specific Aim

Page 23: Alteration of  Chemotaxis  in the Gut of IBD Patients

Paper 2

Page 24: Alteration of  Chemotaxis  in the Gut of IBD Patients

Lumican

Found in connective tissue rich in fibrillar collagens

Deficiency impairs connective tissue function

Promotes neutrophil migration by interacting with neutrophil migration receptor MAC1 or CD11b or CD18

Expression is upregulated in epithelial cells after injury

Goal: characterize the role of lumican in regulating immune response during inflammation

http://onlinelibrary.wiley.com/doi/10.1111/febs.12210/full

Page 25: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 1: Summary of TNBS colitis model

Page 26: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 2: Response to intrarectal TNBS treatment using saline or ethanol as controls

Conclusion: Lum -/- TNBS-treated mice displayed more pronounced adverse effects to TNBS treatment than the WT strain.

Page 27: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 3: Macroscopic appearance of Lum +/+ and Lum -/- colons from saline vs. TNBS-treated mice

Page 28: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 4: Increased inflammation of colons in Lum+/+ and Lum-/- mice

Conclusion: colonic edema and swelling is increased in Lum-/- mice.

Page 29: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 5: Is early acute inflammatory response T cell-mediated or innate immune driven?

Conclusion: Early stages of TNBS induced colitis involves an innate immune response

Rag1-/- mice do not have mature B or T cells.

Page 30: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 6: Histology of colon cross sections from Lum+/+ and Lum-/- mice

Page 31: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 7: Inflammation scores and MPO expression

Conclusion: Lum-/- colons have more tissue damage but less neutrophil infiltration after TNBS colitis induction.

Page 32: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 8: Induction of proinflammatory cytokines in inflamed colonic tissue

Conclusion: TNBS colitis induced CXCL1/KC and TNFα production in Lum+/+ but not Lum-/- colonic tissue.

Page 33: Alteration of  Chemotaxis  in the Gut of IBD Patients

Figure 9: NF-κB activation in Lum +/+ vs. Lum-/- mice

1º peritoneal cells

Conclusion: delayed nuclear localization of NF-κB in Lum-/- colonic samples suggests a weak innate immune response in the absence of lumican.

Page 34: Alteration of  Chemotaxis  in the Gut of IBD Patients

Conclusions from Paper 2

Lumican deficiency leads to decreased neutrophil infiltration but increased severity of colitis

Lumican plays a role in regulation of inflammation in colitis CXCL1 TNF-α Neutrophil recruitment

Page 35: Alteration of  Chemotaxis  in the Gut of IBD Patients

What is still unknown about neutrophil chemotaxis in IBD?

Well, a lot of things.

ECM proteins and their degradation products Several are ECM proteins are upregulated in inflamed colonic tissue

of IBD patients Neutrophils themselves produce proteases whose products further

perpetuate their infiltration

Role of upregulated ECM proteins in the perpetuation of neutrophil infiltration in IBD is poorly studied.

Mechanism of action of ECM proteins/protease products on neutrophil recruitment is poorly understood

Page 36: Alteration of  Chemotaxis  in the Gut of IBD Patients

Specific Aim and Future Directions

Specific Aim Determine a set of ECM proteins and their

degradation products upregulated in inflamed colonic tissue in IBD that can be chemoattractants for neutrophils

Potential experiments Electric cell-substrate impedance sensing (ECIS)/Taxis

to determine potency of chemoattraction induced by various ECM proteins and degradation products

Determine mechanism of action of these proteins by blocking CXCR receptors

Page 37: Alteration of  Chemotaxis  in the Gut of IBD Patients

Thanks for listening!